Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease

NCT02079909 is registered in ClinicalTrials.gov with FUJIFILM Toyama Chemical Co., Ltd. as lead sponsor.

NCT NCT02079909
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02079909 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Lead sponsor
FUJIFILM Toyama Chemical Co., Ltd.
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2014
Completion date
May 5, 2017
Enrollment
482 (actual)
Sites
50

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease